Thomas Wiggans

Thomas Wiggans

Presidente presso JASPER THERAPEUTICS, INC.

Patrimonio netto: 38 134 $ in data 31/05/2026

74 anni
Health Technology
Commercial Services
Consumer Services

Profilo

Thomas G.
Wiggans
is the founder of Dermira, Inc., founded in 2010.
Current jobs include Chairman at The Biotechnology Institute, Executive Chairman at Follica, Inc. since 2021, Executive Chairman at Jasper Therapeutics, Inc. starting 2026, Director at Forma Therapeutics, Inc., Director at The Hoover Institution, Independent Director at Pacira Biosciences, Inc. starting 2026, Trustee at Kansas University Endowment Association, Trustee at Kansas Association of Defense Counsel, and Trustee at Wiggans Living Trust.
Former jobs include Chairman & Chief Executive Officer at Connetics Corp.
(1994–2006), Chairman & Chief Executive Officer at Peplin, Inc. (2007–2009), Chairman & Chief Executive Officer at Pardes Biosciences, Inc. (2022–2023), Chairman at Excaliard Pharmaceuticals, Inc. (2010–2011), Chairman at Annexon, Inc. (2017–2026), Independent Director at Onyx Pharmaceuticals, Inc. (2005–2013), Director at Abgenix, Inc., Independent Director at Sangamo Therapeutics, Inc. (2008–2012), Director at Corthera, Inc., Director at Tercica, Inc. (2005–2006), Independent Director at Somaxon Pharmaceuticals, Inc. (2008–2012), Independent Director at Forma Therapeutics Holdings, Inc. (2020–2022), Director at Victory Pharma, Inc., Director at Neothetics, Inc. (2011–2014), Independent Director at CymaBay Therapeutics, Inc. (2021–2024), Director at Biotechnology Innovation Organization, Principal at Eli Lilly & Co., President & Chief Operating Officer at CytoTherapuetics, Inc. (1992–1994), and President-US Pharmaceutical Operations at Ares-Serono Group (1980–1992).
Education includes an MBA from Southern Methodist University conferred in 1976 and an undergraduate degree from the University of Kansas conferred in 1975.

Partecipazioni note in società pubbliche

SocietàDataNumero di azioniValutazioneData di valutazione
01/06/2026 46.000 ( 0,16% ) 38 134 $ 31/05/2026
31/03/2026 0 ( -.--% ) - $ 31/05/2026

Posizioni attive di Thomas Wiggans

SocietàPosizioneInizio
JASPER THERAPEUTICS, INC. Presidente 01/11/2023
PACIRA BIOSCIENCES, INC. Direttore/Membro del Consiglio 09/06/2026
Direttore/Membro del Consiglio -
Presidente 14/01/2021
Wiggans Living Trust
Direttore/Membro del Consiglio -
Direttore/Membro del Consiglio 29/07/2009
Direttore/Membro del Consiglio 29/07/2009
Presidente -
Direttore/Membro del Consiglio -

Precedenti posizioni note di Thomas Wiggans

SocietàPosizioneFine
░░░░░░░░ ░░░░ ░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░░░░░░░░ ░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░░
Vedi nel dettaglio l'esperienza di Thomas Wiggans

Formazione di Thomas Wiggans

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

72

Relazioni di 1° grado

31

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private31

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Finance

Consumer Services

Health Technology

Commercial Services

Commercial Services

Commercial Services

Health Technology

Consumer Services

Health Technology

Health Technology

Commercial Services

Health Technology

Wiggans Living Trust

Health Technology

Health Technology

  1. Mercati
  2. Insiders
  3. Thomas Wiggans